Capital World Investors
GOSS icon

Capital World Investors’s Gossamer Bio GOSS Stock Holding History

Capital World Investors’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-99,858
Closed -$966K – 612
2020
Q4 		$966K Sell
99,858
-212,142
-68% -$2.09M ﹤0.01% 554
2020
Q3 		$3.87M Hold
312,000
– – ﹤0.01% 531
2020
Q2 		$4.06M Hold
312,000
– – ﹤0.01% 499
2020
Q1 		$3.17M Hold
312,000
– – ﹤0.01% 486
2019
Q4 		$4.88M Hold
312,000
– – ﹤0.01% 481
2019
Q3 		$5.24M Hold
312,000
– – ﹤0.01% 494
2019
Q2 		$6.92M Hold
312,000
– – ﹤0.01% 498
2019
Q1 		$6.76M Buy
+312,000
New +$6.51M ﹤0.01% 491

Other funds holding GOSS

HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return

Capital World Investors's GOSS Position: Q1 2021 in Review

Capital World Investors sold out of Gossamer Bio (GOSS) in Q1 2021, closing a stake of 99,858 shares — an estimated $966K sold.

Capital World Investors first reported a position in GOSS in Q1 2019 and held it in 8 quarters. The position peaked at $6.92M in Q2 2019. 123 funds tracked by Wall St. Rank hold GOSS as of Q1 2021.

  • Capital World Investors reported no remaining Gossamer Bio position as of Q1 2021 after selling out during the quarter.
  • Capital World Investors sold 99,858 Gossamer Bio shares in Q1 2021, an estimated $966K.
  • Capital World Investors first reported a position in Gossamer Bio in Q1 2019 and held it in 8 quarters.
  • Capital World Investors's Gossamer Bio position peaked at $6.92M in Q2 2019.
  • 123 funds tracked by Wall St. Rank held Gossamer Bio as of Q1 2021.

Based on Capital World Investors's 13F filing for Q1 2021, filed 14 May 2021.